Issuu on Google+

ReportLinker

Find Industry reports, Company profiles and Market Statistics

>> Get this Report Now by email!

Pharmaceutical Diversification Trends 2012 Published on June 2012

Report Summary Pharmaceutical companies are facing unprecedented pressures including revenue loss due to the patent cliff and growing healthcare cost containment measures introduced in most developed markets. As a result, they have been forced to reassess their strategies, with diversification beyond branded small molecule products and branded pharmaceuticals in general representing an obvious route.Analysis of the historical merger, acquisition and divestment trends of the top 10 pharmaceutical companies.Insight into the main diversification strategies employed by pharma, as well as analysis of the top 10 sectors pharma is diversifying into.Case study analysis comparing and contrasting the diversification strategies of the top 10 pharma companies.The branded prescription pharma sector is the most profitable healthcare sector. Provided that profit margins associated with innovative drug development remain high, pharma companies that have been successful in replenishing their pipelines with new drugs that lead to successful launches can do no better than to stick with what they do best.While the innovation-driven diversification results in greater profitability, companies facing an imminent revenue drop due to weak launch portfolios are turning towards de-risking diversification, which enables them to close the revenue gap by entering low risk sectors such as consumer health and generics.Divestment deals have been dominated by pharma's strategy to strip out manufacturing in order to become more focused on R&D and marketing, as well as to cut costs, while divestments in other non-pharma sectors have largely involved the sale of certain assets rather than the divestment of an entire unit or exit from a particular sector altogether.What are the key drivers and resistors driving pharma companies towards becoming increasingly diversified'Which healthcare sectors offer the greatest synergies'What are the benefits and draw backs of innovation-driven diversification and de-risking diversification'

Pharmaceutical Diversification Trends 2012 (From Issuu)

Page 1/3


Find Industry reports, Company profiles and Market Statistics

ReportLinker

>> Get this Report Now by email! Fax Order Form To place an order via fax simply print this form, fill in the information below and fax the completed form to: ƒ ƒ

Europe, Middle East and Africa : + 33 4 37 37 15 56 Asia, Oceania and America : + 1 (805) 617 17 93

If you have any questions please visit http://www.reportlinker.com/notify/contact

Order Information Please verify that the product information is correct and select the format(s) you require. Pharmaceutical Diversification Trends 2012

Product Formats Please select the product formats and the quantity you require. 1 User License--USD 7 600.00

Quantity: _____

Corporate License--USD 19 000.00

Quantity: _____

Contact Information Please enter all the information below in BLOCK CAPITALS

Title:

Mr

Mrs

Dr

Miss

Ms

Prof

First Name:

_____________________________ Last Name: __________________________________

Email Address:

__________________________________________________________________________

Job Title:

__________________________________________________________________________

Organization:

__________________________________________________________________________

Address:

__________________________________________________________________________

City:

__________________________________________________________________________

Postal / Zip Code:

__________________________________________________________________________

Country:

__________________________________________________________________________

Phone Number:

__________________________________________________________________________

Fax Number:

__________________________________________________________________________

Pharmaceutical Diversification Trends 2012 (From Issuu)

Page 2/3


Find Industry reports, Company profiles and Market Statistics

ReportLinker

>> Get this Report Now by email! Payment Information Please indicate the payment method, you would like to use by selecting the appropriate box.

Payment by credit card

Card Number: ______________________________________________

Expiry Date

__________ / _________

CVV Number _____________________

Card Type (ex: Visa, Amex…) _________________________________

Payment by wire transfer

Crédit Mutuel RIB : 10278 07314 00020257701 89 BIC : CMCIFR2A IBAN : FR76 1027 8073 1400 0202 5770 189

Payment by check

UBIQUICK SAS 16 rue Grenette – 69002 LYON, FRANCE

Customer signature:

 

Please note that by ordering from Reportlinker you are agreeing to our Terms and Conditions at http://www.reportlinker.com/index/terms

Please fax this form to: Europe, Middle East and Africa : + 33 4 37 37 15 56

ƒ ƒ

Pharmaceutical Diversification Trends 2012 (From Issuu)

Asia, Oceania and America : + 1 (805) 617 17 93

Page 3/3


Pharmaceutical Diversification Trends 2012